For non-small lung cancer, Zolov et al. developed a new CAR construct targeting cell adhesion molecule 1 (CADM1), which showed increased cytotoxicity against CADM1-expressing lung cancer cells in comparison to non-transduced NK92 cells [107]. Here, CADM1 is linked to lung cancer.